His Health Service Agency (NHS) has just begun to conduct the world's largest test for Galleri blood testing method of Grail Biotechnology Company. This is a testing method that is capable of detecting 50 cancers earlier before symptoms of disease appearing. The test is named "Galleri blood test", which will be based on the patient's blood DNA structure Detect abnormal signs from cancer cells. NHS said, this agency wants to find 140,000 volunteers from 50-77 years old, in England area, to monitor the testing effect within the framework of controlled randomized trials. Participants will receive blood samples at other mobile and other facilities nationwide clinics
. After 12 months, they will receive a closed blood sample and again after 2 years. Reuters news leads Mr. Amanda Pritchard, NHS CEO, said blood tests can mark the beginning of the meeting Revolution in cancer detection and treatment, giving people the opportunity to survive the best possible, significantly reducing late diagnostic cases for cancer
Galleri blood tests can play an important role in achieving the ambitious long-term plan of NHS as "catching" 3/4 cancers in the early stages, while it is easy to treat. The first results from the study were expected to be announced in 2023. If successful, NHS plans to expand the implementation of 1 million more people in 2024 and 2025.Khanh Hung . Dịch vụ:
Thiết kế website,
quảng cáo google,
đăng ký website bộ công thương uy tín
